United Kingdom of Great Britain and Northern Ireland

9 Vaccines Approved for Use in United Kingdom of Great Britain and Northern Ireland

Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
Approval Source: gov.uk
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: bbc.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: nytimes.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: bbc.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: astrazeneca.com
Inactivated

Valneva

VLA2001

Approved in 33 countries
9 trials in 4 countries
Approval Source: gov.uk
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.1

Approved in 38 countries
5 trials in 4 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.1

Approved in 35 countries
3 trials in 5 countries
Approval Source: theguardian.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: bbc.com

15 in Clinical Trials in United Kingdom of Great Britain and Northern Ireland

Protein Subunit

Sanofi/GSK

Recombinant Protein

6 trials in 7 countries
Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
VLP

Medicago

Covifenz

Approved in 1 country
6 trials in 6 countries
RNA

Moderna

mRNA-1273.529

4 trials in 1 country
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

AZD2816

2 trials in 2 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Inactivated

Valneva

VLA2001

Approved in 33 countries
9 trials in 4 countries
Live-Attenuated

Codagenix Inc

COVI-VAC

3 trials in 1 country
RNA

Gritstone Bio, Inc.

GRT-R910

Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.1

Approved in 38 countries
5 trials in 4 countries
RNA

Moderna

mRNA-1230

3 Vaccines with Trials in United Kingdom of Great Britain and Northern Ireland are No Longer Progressing

RNA

Curevac

CVnCoV

9 trials in 12 countries
RNA

Imperial

LNP-nCoVsaRNA

Non Replicating Viral Vector

Oxford/AstraZeneca

AZD2816

2 trials in 2 countries